食管切除术后吻合口并发症:倾向加权队列中大网膜成形术的影响
本研究纳入245例接受新辅助放化疗后微创食管切除术的患者,其中147例(60%)行吻合口大网膜成形术。采用增强逆概率治疗加权法调整21项术前变量后,发现大网膜成形术与吻合口漏风险、主要并发症及死亡率均无显著差异。
要点
- 新辅助放化疗后食管切除患者中,大网膜成形术未降低吻合口漏发生率(13.2% vs 14.3%)。
- 大网膜成形术与主要并发症风险(27.9% vs 32.6%)及死亡率(6.7% vs 4.8%)均无显著关联。
- 总体吻合口漏率为15%,漏相关死亡率为13%(5/37)。
核心结论
- 在新辅助放化疗后的食管切除术中,吻合口大网膜成形术未显示降低吻合口漏率或漏相关再手术需求。
研究设计与样本
- 回顾性队列研究,纳入2001-2016年接受新辅助放化疗后微创食管切除术的患者245例,其中大网膜成形术147例(60%)。
- 采用基于21项术前变量的增强逆概率治疗加权法进行倾向评分调整。
主要发现
- 总体吻合口漏率为15%,漏相关死亡率为13%(37例漏中5例死亡)。
临床怎么用
- 对于新辅助放化疗后的食管切除术患者,不应常规期望通过吻合口大网膜成形术来降低吻合口漏风险。
局限性
- 样本量有限且为回顾性设计,统计方法存在局限性,可能无法排除未测量混杂因素的影响。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: A recent meta-analysis of 3 randomized controlled trials reported reduced incidence and severity of postesophagectomy anastomotic dehiscence with anastomotic omentoplasty. Unfortunately, these trials excluded neoadjuvant patients who received chemoradiation. We aimed to determine whether anastomotic omentoplasty was associated with differential postesophagectomy anastomotic complications after neoadjuvant chemoradiotherapy. METHODS: Data for patients who underwent minimally invasive esophagectomy following neoadjuvant chemoradiotherapy were abstracted (n = 245; 2001-2016; omentoplasty = 147 [60%]). Propensity for omentoplasty was estimated on 21 pretreatment variables, using augmented inverse probability of treatment weights, and used to determine the adjusted proportion of adverse anastomotic outcomes, major morbidity, and 30-day/in-hospital mortality. RESULTS: Overall, anastomotic leak rate was 15%; leak-associated mortality was 13% (n = 5 out of 37). Leak rates (omentoplasty n = 24 [16%] vs no omentoplasty n = 13 [13%]; P = .512) and incidence of any major complications (48% vs 48%; P = .958) were similar. Leaks requiring surgical intervention occurred in 12 patients (5% vs 5%; P = .904). Propensity weighting achieved excellent balance across all 21 pretreatment variables (before weighting, standardized differences ranged from -0.23 to 0.35; postweighting standardized differences ranged from -0.09 to 0.07). In propensity-weighted data, omentoplasty was not associated with differential adjusted risk of anastomotic leak (13.2% vs 14.3%; P = .83), major morbidity (27.9% vs 32.6%; P = .44), or mortality (6.7% vs 4.8%; P = .61). CONCLUSIONS: Within the limits of our sample size and statistical approach, our study failed to find evidence that anastomotic omentoplasty during esophagectomy after neoadjuvant chemoradiation reduced anastomotic leak rate or need for leak-related reoperation.
引用
- Lu M, Luketich JD, Levy RM, et al. Anastomotic complications after esophagectomy: Influence of omentoplasty in propensity-weighted cohorts. J Thorac Cardiovasc Surg. 2019. PMID: 31932061. doi:10.1016/j.jtcvs.2019.09.157
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。